[{"PropertyPlantAndEquipmentNet_0_Q1_USD":33862000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"LiabilitiesNoncurrent_0_Q1_USD":103061000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":20896000.0,"InterestPaidNet_1_Q1_USD":1410000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":2347000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-3876000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q1_USD":27699000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":45468485.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-7560000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":12375000.0,"DerivativeGainLossOnDerivativeNet_1_Q1_USD":5342000.0,"ProceedsFromIssuanceOfLongTermDebt_1_Q1_USD":34603000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":4143357.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":392000.0,"CommonStockSharesIssued_0_Q1_shares":45924729.0,"Assets_0_Q1_USD":363853000.0,"AssetsCurrent_0_Q1_USD":282330000.0,"DepreciationAndAmortization_1_Q1_USD":1862000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":400000.0,"Liabilities_0_Q1_USD":135163000.0,"PrepaidExpenseCurrent_0_Q1_USD":9186000.0,"OtherExpenses_1_Q1_USD":233000.0,"AccountsReceivableNetCurrent_0_Q1_USD":5445000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":213000.0,"CommonStockValue_0_Q1_USD":2780000.0,"SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_1_Q1_USD":15800000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":4626000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":0.005,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":62618000.0,"CostsAndExpenses_1_Q1_USD":45031000.0,"PaymentsOfStockIssuanceCosts_1_Q1_USD":1161000.0,"OtherAssetsCurrent_0_Q1_USD":6886000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-41556000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":-49116000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":2510000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":260813000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":29487000.0,"ShareBasedCompensation_1_Q1_USD":5761000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":25313000.0,"ProceedsFromIssuanceOfCommonStock_1_Q1_USD":442000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":16206000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":15849000.0,"CommonStockSharesOutstanding_0_Q1_shares":45924729.0,"RestrictedCashNoncurrent_0_Q1_USD":2716000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q1_USD":35900000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q1_USD":-7560000.0,"Goodwill_0_Q1_USD":518000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":5761000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-41273000.0,"LiabilitiesCurrent_0_Q1_USD":32102000.0,"AccountsPayableCurrent_0_Q1_USD":5749000.0,"InterestExpense_1_Q1_USD":1551000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":263529000.0,"LongTermDebtNoncurrent_0_Q1_USD":70467000.0,"EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_1_Q1_pure":0.25,"AdditionalPaidInCapital_0_Q1_USD":1049850000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q1_USD":49000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":2908000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-826287000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-1620000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":454000.0,"OtherIncome_1_Q1_USD":352000.0,"CommonStockParOrStatedValuePerShare_0_Q1_EUR":0.05,"DeferredTaxAssetsNet_0_Q1_USD":200000.0,"CommonStockSharesAuthorized_0_Q1_shares":60000000.0,"OperatingIncomeLoss_1_Q1_USD":-44458000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":-41343000.0,"ProceedsFromIssuanceInitialPublicOffering_1_Q1_USD":28734000.0,"InvestmentIncomeInterest_1_Q1_USD":40000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":363853000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":4716000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":5457000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_1_Q1_USD":3302000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.91,"ProfitLoss_1_Q1_USD":-41556000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":3107000.0,"OtherLiabilitiesCurrent_0_Q1_USD":5000000.0,"StockholdersEquity_0_Q1_USD":228690000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":3876000.0,"AssetsNoncurrent_0_Q1_USD":81523000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":32656000.0,"Ticker":"QURE","CIK":"1590560","name":"UNIQURE N.V.","OfficialName":"uniQure N.V. Ordinary Shares","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"814390930.0","Country":"Netherlands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210510"}]